NCT00056199
- Conditions
- Abnormalities, Multiple, Angiomatosis, Cardiovascular Diseases, +27 more
- Locations
-
- National Eye Institute (NEI) Bethesda, Maryland, United States
Clinical trial condition
Peripheral Nervous System Neoplasms
Explore clinical trials studying Peripheral Nervous System Neoplasms. Study availability and eligibility vary by location and protocol.
257 public trials
48 recruiting studies
Peripheral Nervous System Neoplasms trial results
Active, Not Recruiting
Natural History Study of Patients With Neurofibromatosis Type I
NCT00924196
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +38 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Active, Not Recruiting
AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors
NCT01362803
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +22 more
- Locations
-
- Children's National Medical Center Washington D.C., District of Columbia, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
Active, Not Recruiting
MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas
NCT03962543
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +18 more
- Locations
-
- University of Alabama at Birmingham/Children's of Alabama Birmingham, Alabama, United States
- Mayo Clinic Arizona Phoenix, Arizona, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
Active, Not Recruiting
Pediatric Long-Term Follow-up and Rollover Study
NCT03975829
- Conditions
- Anaplastic Astrocytoma, Anaplastic Ganglioglioma, Anaplastic Oligodendroglioma, +62 more
- Locations
-
- Phoenix Children s Hospital Phoenix, Arizona, United States
- Childrens National Hospital Washington D.C., District of Columbia, United States
- Nicklaus Childrens Hospital Miami, Florida, United States
- Indiana Uni School of Medicine Indianapolis, Indiana, United States
Active, Not Recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
- Conditions
- Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
Active, Not Recruiting
A Study of Avutometinib for People With Solid Tumor Cancers
NCT06104488
- Conditions
- Brain Diseases, Brain Neoplasms, CNS Tumor, Adult, +34 more
- Locations
-
- Children's Healthcare of Atlanta (Data Collection Only) Atlanta, Georgia, United States
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States
Active, Not Recruiting
Tazemetostat in Malignant Peripheral Nerve Sheath Tumors
NCT04917042
- Conditions
- Behavior, Fibrosarcoma, Inhibition, Psychological, +16 more
- Locations
-
- University of Florida Gainesville, Florida, United States
Active, Not Recruiting
A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)
NCT04590235
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +17 more
- Locations
-
- Research Site Shanghai, China
- Research Site Shanghai, China
Active, Not Recruiting
Observational Study to Evaluate the Effect and Safety of Selumetinib in Pediatric Patients With NF1-PNs
NCT06175637
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Nerve Tissue, +8 more
- Locations
-
- Research Site Beijing, Beijing Municipality, China
- Research Site Chongqing, Chongqing Municipality, China
- Research Site Lanzhou, Gansu, China
- Research Site Guangzhou, Guangdong, China